Clinical Trial Detail

Contact

Missing content? – Request curation!

Request curation for specific Genes, Variants, or PubMed publications.

Have questions, comments, or suggestions? - Let us know!

Email us at : ckbsupport@jax.org

NCT ID NCT02412371
Title A Study Evaluating the Efficacy and Tolerability of Veliparib in Combination With Paclitaxel/Carboplatin-Based Chemoradiotherapy Followed by Veliparib and Paclitaxel/Carboplatin Consolidation in Subjects With Stage III Non-Small Cell Lung Cancer
Recruitment Terminated
Gender both
Phase Phase II
Variant Requirements No
Sponsors AbbVie
Indications
Therapies
Age Groups: adult
Covered Countries USA

Facility Status City State Zip Country Details
Ucsd /Id# 133037 La Jolla California 92093 United States Details
Christiana Care Health Service /ID# 133486 Newark Delaware 19713 United States Details
University of Chicago /ID# 133828 Chicago Illinois 60637-1443 United States Details
Univ Maryland School Medicine /ID# 132944 Baltimore Maryland 21201 United States Details
Dana-Farber Cancer Institute /ID# 133494 Boston Massachusetts 02215 United States Details
SUNY Upstate Medical University - Downtown /ID# 133492 Syracuse New York 13210 United States Details
Unc /Id# 133496 Chapel Hill North Carolina 27599 United States Details
Duke University Medical Center /ID# 133497 Durham North Carolina 27710-3000 United States Details
Wake Forest Univ HS /ID# 134608 Winston-Salem North Carolina 27157 United States Details
Rhode Island Hospital /ID# 133493 Providence Rhode Island 02903 United States Details
The Miriam Hospital /ID# 133910 Providence Rhode Island 02906 United States Details
University of Virginia /ID# 133495 Charlottesville Virginia 22908 United States Details
*Shaded cells indicate that there was no data available from clincialtrials.gov for the field